A citation-based method for searching scientific literature

Zsofia Sztupinszki, Miklos Diossy, Marcin Krzystanek, Lilla Reiniger, István Csabai, Francesco Favero, Nicolai J Birkbak, Aron C Eklund, Ali Syed, Zoltan Szallasi. NPJ Breast Cancer 2018
Times Cited: 66



Melinda L Telli, Kirsten M Timms, Julia Reid, Bryan Hennessy, Gordon B Mills, Kristin C Jensen, Zoltan Szallasi, William T Barry, Eric P Winer, Nadine M Tung, Steven J Isakoff, Paula D Ryan, April Greene-Colozzi, Alexander Gutin, Zaina Sangale, Diana Iliev, Chris Neff, Victor Abkevich, Joshua T Jones, Jerry S Lanchbury, Anne-Renee Hartman, Judy E Garber, James M Ford, Daniel P Silver, Andrea L Richardson. Clin Cancer Res 2016
Times Cited: 438




List of shared articles



Times cited


Comparative Assessment of Diagnostic Homologous Recombination Deficiency-Associated Mutational Signatures in Ovarian Cancer.
Zsofia Sztupinszki, Miklos Diossy, Judit Borcsok, Aurel Prosz, Nanna Cornelius, Maj K Kjeldsen, Mansoor R Mirza, Zoltan Szallasi. Clin Cancer Res 2021
3

Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer.
Vanessa F Bonazzi, Olga Kondrashova, Deborah Smith, Katia Nones, Asmerom T Sengal, Robert Ju, Leisl M Packer, Lambros T Koufariotis, Stephen H Kazakoff, Aimee L Davidson,[...]. Genome Med 2022
3

Differential whole-genome doubling and homologous recombination deficiencies across breast cancer subtypes from the Taiwanese population.
Chia-Hsin Wu, Chia-Shan Hsieh, Yo-Cheng Chang, Chi-Cheng Huang, Hsien-Tang Yeh, Ming-Feng Hou, Yuan-Chiang Chung, Shih-Hsin Tu, King-Jen Chang, Amrita Chattopadhyay,[...]. Commun Biol 2021
0

Detection of Molecular Signatures of Homologous Recombination Deficiency in Bladder Cancer.
Judit Börcsök, Miklos Diossy, Zsofia Sztupinszki, Aurel Prosz, Viktoria Tisza, Sandor Spisak, Orsolya Rusz, Dag R Stormoen, Helle Pappot, Istvan Csabai,[...]. Clin Cancer Res 2021
8

PARP inhibitors for metastatic castration-resistant prostate cancer: Biological rationale and current evidence.
Michał Bieńkowski, Bartłomiej Tomasik, Marcin Braun, Jacek Jassem. Cancer Treat Rev 2022
1

Simple prediction model for homologous recombination deficiency in breast cancers in adolescents and young adults.
Tomoko Watanabe, Takayuki Honda, Hirohiko Totsuka, Masayuki Yoshida, Maki Tanioka, Kouya Shiraishi, Yoko Shimada, Eri Arai, Mineko Ushiama, Kenji Tamura,[...]. Breast Cancer Res Treat 2020
1

A Risk Model Developed Based on Homologous Recombination Deficiency Predicts Overall Survival in Patients With Lower Grade Glioma.
Hao Peng, Yibiao Wang, Pengcheng Wang, Chuixue Huang, Zhaohui Liu, Changwu Wu. Front Genet 2022
0

PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancer.
Kasia M Dillon, Raie T Bekele, Zsofia Sztupinszki, Timothy Hanlon, Shahrzad Rafiei, Zoltan Szallasi, Atish D Choudhury, Kent W Mouw. NPJ Precis Oncol 2022
0

Establishment and validation of a prognostic model based on HRR-related lncRNAs in colon adenocarcinoma.
Xingkui Tang, Yukun Lin, Jialin He, Xijun Luo, Junjie Liang, Xianjun Zhu, Tao Li. World J Surg Oncol 2022
0

Discovery and validation of a transcriptional signature identifying homologous recombination-deficient breast, endometrial and ovarian cancers.
Guillaume Beinse, Pierre-Alexandre Just, Marie-Aude Le Frere Belda, Pierre Laurent-Puig, Sebastien Jacques, Meriem Koual, Simon Garinet, Karen Leroy, Nicolas Delanoy, Helene Blons,[...]. Br J Cancer 2022
0

Current gene panels account for nearly all homologous recombination repair-associated multiple-case breast cancer families.
Thibaut S Matis, Nadia Zayed, Bouchra Labraki, Manon de Ladurantaye, Théophane A Matis, José Camacho Valenzuela, Nancy Hamel, Adrienne Atayan, Barbara Rivera, Yuval Tabach,[...]. NPJ Breast Cancer 2021
1

Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer.
Navonil De Sarkar, Sayan Dasgupta, Payel Chatterjee, Ilsa Coleman, Gavin Ha, Lisa S Ang, Emily A Kohlbrenner, Sander B Frank, Talina A Nunez, Stephen J Salipante,[...]. JCI Insight 2021
0

Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion.
Sara A Byron, William P D Hendricks, Abhinav B Nagulapally, Jacqueline M Kraveka, William S Ferguson, Valerie I Brown, Don E Eslin, Deanna Mitchell, Albert Cornelius, William Roberts,[...]. Cancer Res 2021
2

Using whole-genome sequencing data to derive the homologous recombination deficiency scores.
Xavier M de Luca, Felicity Newell, Stephen H Kazakoff, Gunter Hartel, Amy E McCart Reed, Oliver Holmes, Qinying Xu, Scott Wood, Conrad Leonard, John V Pearson,[...]. NPJ Breast Cancer 2020
4

A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures.
Miklos Diossy, Zsofia Sztupinszki, Judit Borcsok, Marcin Krzystanek, Viktoria Tisza, Sandor Spisak, Orsolya Rusz, Jozsef Timar, István Csabai, Janos Fillinger,[...]. NPJ Precis Oncol 2021
4

Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response.
Hyeon Gu Kang, Haeun Hwangbo, Myung Ji Kim, Sinae Kim, Eun Ji Lee, Min Ji Park, Jae-Weon Kim, Byoung-Gie Kim, Eun-Hae Cho, Suhwan Chang,[...]. Cancer Res 2022
0

Efficacy of platinum-based chemotherapy in metastatic breast cancer and HRD biomarkers: utility of exome sequencing.
Loïck Galland, Elise Ballot, Hugo Mananet, Romain Boidot, Julie Lecuelle, Juliette Albuisson, Laurent Arnould, Isabelle Desmoulins, Didier Mayeur, Courèche Kaderbhai,[...]. NPJ Breast Cancer 2022
0

Determining homologous recombination deficiency scores with whole exome sequencing and their association with responses to neoadjuvant chemotherapy in breast cancer.
Seung Jin Kim, Yoshiaki Sota, Yasuto Naoi, Keiichiro Honma, Naofumi Kagara, Tomohiro Miyake, Masafumi Shimoda, Tomonori Tanei, Shigeto Seno, Hideo Matsuda,[...]. Transl Oncol 2021
2

Evolutionary Trajectories and Genomic Divergence in Localized Breast Cancers after Ipsilateral Breast Tumor Recurrence.
Chia-Hsin Wu, Hsien-Tang Yeh, Chia-Shan Hsieh, Chi-Cheng Huang, Amrita Chattopadhyay, Yuan-Chiang Chung, Shih-Hsin Tu, Yung-Hua Li, Tzu-Pin Lu, Liang-Chuan Lai,[...]. Cancers (Basel) 2021
0

Characterisation of PALB2 tumours through whole-exome and whole-transcriptomic analyses.
Pei Sze Ng, Jia Wern Pan, Muhammad Mamduh Ahmad Zabidi, Pathmanathan Rajadurai, Cheng Har Yip, Oscar M Reuda, Alison M Dunning, Antonis C Antoniou, Douglas F Easton, Carlos Caldas,[...]. NPJ Breast Cancer 2021
2

Acquired RAD51C Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma.
Ksenija Nesic, Olga Kondrashova, Rachel M Hurley, Cordelia D McGehee, Cassandra J Vandenberg, Gwo-Yaw Ho, Elizabeth Lieschke, Genevieve Dall, Nirashaa Bound, Kristy Shield-Artin,[...]. Cancer Res 2021
9


MutScape: an analytical toolkit for probing the mutational landscape in cancer genomics.
Cheng-Hua Lu, Chia-Hsin Wu, Mong-Hsun Tsai, Liang-Chuan Lai, Eric Y Chuang. NAR Genom Bioinform 2021
0

Detection of Molecular Signatures of Homologous Recombination Deficiency in Prostate Cancer with or without BRCA1/2 Mutations.
Zsofia Sztupinszki, Miklos Diossy, Marcin Krzystanek, Judit Borcsok, Mark M Pomerantz, Viktoria Tisza, Sandor Spisak, Orsolya Rusz, István Csabai, Matthew L Freedman,[...]. Clin Cancer Res 2020
32

Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway Genes.
Evan Rosenbaum, Philip Jonsson, Kenneth Seier, Li-Xuan Qin, Ping Chi, Mark Dickson, Mrinal Gounder, Ciara Kelly, Mary L Keohan, Benjamin Nacev,[...]. JCO Precis Oncol 2020
10

Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancer.
Alok K Tewari, Alexander T M Cheung, Jett Crowdis, Jake R Conway, Sabrina Y Camp, Stephanie A Wankowicz, Dimitri G Livitz, Jihye Park, Rosina T Lis, Alice Bosma-Moody,[...]. Cell Rep 2021
5

Multi-Gene Testing Overview with a Clinical Perspective in Metastatic Triple-Negative Breast Cancer.
Martina Dameri, Lorenzo Ferrando, Gabriella Cirmena, Claudio Vernieri, Giancarlo Pruneri, Alberto Ballestrero, Gabriele Zoppoli. Int J Mol Sci 2021
2

Biomarker Assessment of Homologous Recombination Deficiency in Epithelial Ovarian Cancer: Association With Progression-Free Survival After Surgery.
Huan Yi, Linhong Li, Jimiao Huang, Zhiming Ma, Hongping Li, Jian Chen, Xiangqin Zheng, Jingjing Chen, Haixin He, Jianrong Song. Front Mol Biosci 2022
0

Pan-cancer analysis reveals homologous recombination deficiency score as a predictive marker for immunotherapy responders.
Can Yang, Zijing Zhang, Xuemei Tang, Xinju Zhang, Yuming Chen, Tingting Hu, Huating Zhang, Ming Guan, Xiuming Zhang, Zhiyuan Wu. Hum Cell 2022
4

Association of 17q22 Amplicon Via Cell-Free DNA With Platinum Chemotherapy Response in Metastatic Triple-Negative Breast Cancer.
Katharine A Collier, Sarah Asad, David Tallman, Janet Jenison, Andrei Rajkovic, Elaine R Mardis, Heather A Parsons, Sara M Tolaney, Eric P Winer, Nancy U Lin,[...]. JCO Precis Oncol 2021
1

Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD).
E Rempel, K Kluck, S Beck, I Ourailidis, D Kazdal, O Neumann, A L Volckmar, M Kirchner, H Goldschmid, N Pfarr,[...]. NPJ Precis Oncol 2022
0

Biomarkers for Homologous Recombination Deficiency in Cancer.
Svenja Wagener-Ryczek, Sabine Merkelbach-Bruse, Janna Siemanowski. J Pers Med 2021
6